Recent Finacing
Recent Raise
Vir Biotechnology develops antibody-based therapeutics and vaccines using a proprietary monoclonal-antibody platform, CRISPR screening, and machine-learning to identify antiviral and host-cell targets, collaborating with pharma on clinical development.
